Promoting the State's Quality of Life, New Jersey Symphony Orchestra to Perform at BIO International Convention
PRINCETON, N.J., June 18, 2012 /PRNewswire/ -- The New Jersey Symphony Orchestra Chamber Players will play a feature performance to showcase one of New Jersey's rich cultural assets during a special event for company prospects within the life sciences sector. The event is being hosted by Choose New Jersey, Inc. and Lt. Governor Kim Guadagno on June 19 at the BIO International Convention in Boston.
With renowned conductor Jacques Lacombe as its music director, the New Jersey Symphony Orchestra is a hallmark of musical excellence. The Chamber Players will represent New Jersey's multifaceted cultural assets to select corporate executives in the life science and biotechnology industry.
"While it is important to promote New Jersey's incredible business environment, we believe quality of life is a major asset to living and working in New Jersey," said Tracye McDaniel, president & CEO, Choose New Jersey. "Living in New Jersey provides endless opportunities to take advantage of our strong and diverse cultural centers."
"It is our great pleasure to join Choose New Jersey and the State at BIO International," said Andre Gremillet, president & CEO, New Jersey Symphony Orchestra. "New Jersey is a state where your business can thrive and your family can enjoy a good life. We're pleased and proud to be part of that."
"New Jersey offers great business advantages to companies located here, and provides equally great cultural advantages to our residents. From the natural beauty of our mountains, lakes and 130 miles of beaches, to our unparalleled arts, cultural and historic treasures, New Jerseyans enjoy an enriched quality of life," said Lt. Governor Guadagno. "I am pleased Andre and the renowned New Jersey Symphony Orchestra Chamber Players will join us to make a classic Jersey impression on Boston and the BIO International convention through their music."
Attendees at the event will have the opportunity to network with life sciences companies with operations in New Jersey such as Celgene and Novartis Pharmaceuticals, as well as Lt. Governor Guadagno, and representatives from Choose New Jersey, Inc., the HealthCare Institute of New Jersey, BioNJ, InnovationNJ, New Jersey Life Sciences Vendors Alliance, New Jersey Symphony Orchestra, Princeton University, Rutgers University, New Jersey Institute of Technology (NJIT), and the University of Medicine and Dentistry of New Jersey (UMDNJ).
About Choose New Jersey, Inc.
Choose New Jersey, Inc., a member of the Partnership for Action – including the NJ Business Action Center and the NJ Economic Development Authority, is responsible for executing New Jersey's economic development strategy. Choose New Jersey, Inc. is an independently-funded and operated 501(c)(3) nonprofit corporation created to promote New Jersey as a place to invest and do business. For more information, visit www.chooseNJ.com.
About the New Jersey Symphony Orchestra
The New Jersey Symphony Orchestra, led by Music Director Jacques Lacombe, is comprised of some of the country's finest musicians. Artistic excellence, innovative programming and community engagement are hallmarks of its mission. NJSO programs are made possible in part by the New Jersey State Council on the Arts/Department of State, a partner agency of the National Endowment for the Arts, along with many other foundations, corporations and individual donors. www.njsymphony.org.
Contact: Melissa Hensley, 609-297-2192
SOURCE Choose New Jersey, Inc.Back to top